Anne Labonté

1.1k total citations
29 papers, 305 citations indexed

About

Anne Labonté is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Anne Labonté has authored 29 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in Anne Labonté's work include Alzheimer's disease research and treatments (14 papers), S100 Proteins and Annexins (5 papers) and Dementia and Cognitive Impairment Research (4 papers). Anne Labonté is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), S100 Proteins and Annexins (5 papers) and Dementia and Cognitive Impairment Research (4 papers). Anne Labonté collaborates with scholars based in Canada, Sweden and United Kingdom. Anne Labonté's co-authors include Judes Poirier, Cynthia Picard, Daniel Auld, Pedro Rosa‐Neto, John C.S. Breitner, L Annable, Guy Chouinard, Réjean Fontaine, Sylvia Villeneuve and Pierre‐François Meyer and has published in prestigious journals such as PLoS ONE, Neurology and Cancer Research.

In The Last Decade

Anne Labonté

26 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Labonté Canada 10 127 109 58 54 42 29 305
Brian Fulton‐Howard United States 8 243 1.9× 222 2.0× 98 1.7× 88 1.6× 24 0.6× 11 537
Hairong Liao China 5 127 1.0× 86 0.8× 70 1.2× 77 1.4× 16 0.4× 9 337
Olivier Sol France 9 154 1.2× 129 1.2× 32 0.6× 51 0.9× 27 0.6× 15 382
Ananda Staats Pires Australia 10 80 0.6× 103 0.9× 25 0.4× 59 1.1× 7 0.2× 15 382
Jingxian Sun China 11 46 0.4× 100 0.9× 107 1.8× 26 0.5× 9 0.2× 20 327
Choonghee Lee United States 5 96 0.8× 56 0.5× 102 1.8× 13 0.2× 21 0.5× 7 205
Liina Haring Estonia 11 112 0.9× 140 1.3× 25 0.4× 168 3.1× 10 0.2× 25 469
Chung‐Feng Kao Taiwan 11 72 0.6× 118 1.1× 13 0.2× 93 1.7× 32 0.8× 15 350
Jinhao Sun China 12 69 0.5× 200 1.8× 53 0.9× 22 0.4× 20 0.5× 33 426
Pamela V. Martino Adami Argentina 13 207 1.6× 175 1.6× 70 1.2× 41 0.8× 19 0.5× 20 436

Countries citing papers authored by Anne Labonté

Since Specialization
Citations

This map shows the geographic impact of Anne Labonté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Labonté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Labonté more than expected).

Fields of papers citing papers by Anne Labonté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Labonté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Labonté. The network helps show where Anne Labonté may publish in the future.

Co-authorship network of co-authors of Anne Labonté

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Labonté. A scholar is included among the top collaborators of Anne Labonté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Labonté. Anne Labonté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Picard, Cynthia, et al.. (2024). Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology. Journal of Lipid Research. 65(11). 100667–100667. 2 indexed citations
3.
Picard, Cynthia, Anne Labonté, Erlan Sanchez, et al.. (2024). Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(1). e12521–e12521. 7 indexed citations
4.
Poirier, Alexandre, Cynthia Picard, Anne Labonté, et al.. (2024). PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease. Scientific Reports. 14(1). 14718–14718. 1 indexed citations
5.
Labonté, Anne, Cynthia Picard, Henrik Zetterberg, et al.. (2024). Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease. Alzheimer s & Dementia. 20(9). 6008–6031. 9 indexed citations
7.
Picard, Cynthia, et al.. (2023). Evaluation of HIVEP3 polymorphic variants and gene expression in Alzheimer’s disease. Alzheimer s & Dementia. 19(S12). 1 indexed citations
8.
Picard, Cynthia, Anne Labonté, Erlan Sanchez, et al.. (2023). Day‐to‐day sleep and circadian variability in association with Alzheimer’s Disease biomarkers. Alzheimer s & Dementia. 19(S1). 1 indexed citations
9.
Labonté, Anne, Erlan Sanchez, Cynthia Picard, et al.. (2023). Actigraphy sleep patterns in presymptomatic Alzheimer’s Disease: the potential role of neuroinflammation. Alzheimer s & Dementia. 19(S1). 1 indexed citations
12.
Picard, Cynthia, Nathalie Nilsson, Anne Labonté, et al.. (2021). Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimer s & Dementia. 18(5). 875–887. 36 indexed citations
14.
Nilsson, Nathalie, Cynthia Picard, Anne Labonté, et al.. (2021). Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum. Genes. 12(11). 1805–1805. 4 indexed citations
15.
McSweeney, Melissa, Alexa Pichet Binette, Pierre‐François Meyer, et al.. (2020). Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults. Neurology. 94(11). e1190–e1200. 26 indexed citations
16.
Picard, Cynthia, et al.. (2019). Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study. PLoS ONE. 14(8). e0220254–e0220254. 43 indexed citations
17.
Miron, Justin, Cynthia Picard, Marie‐Élyse Lafaille‐Magnan, et al.. (2019). Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation. Alzheimer s & Dementia. 15(7). 951–960. 25 indexed citations
18.
Meyer, Pierre‐François, Mélissa Savard, Judes Poirier, et al.. (2018). Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer s Disease. 63(2). 577–590. 32 indexed citations
19.
McSweeney, Melissa, Alexa Pichet Binette, Pierre‐François Meyer, et al.. (2018). O1‐03‐06: EARLY INCREASE IN TAU‐PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P‐TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE‐MIDDLE‐AGED ADULTS. Alzheimer s & Dementia. 14(7S_Part_4). 1 indexed citations
20.
Caron, Mireille, et al.. (2011). Abstract 64: Development of homogeneous non-radioactive assays for studying histone 3 methyltransferases and demethylases. Cancer Research. 71(8_Supplement). 64–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026